enVVeno Medical Corp
Ownership
Ownership Structure
Who owns enVVeno Medical Corp (NVNO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.2% of the shares are freely tradable; institutional investors hold 25.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Kingdon Capital Management LLC | 5.21 | 36,166 | +0.0 | 06/30/2026 |
| CM Management, LLC | 5.14 | 35,714 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.50 | 10,455 | +81.8 | 03/31/2026 |
| Vanguard Capital Management, LLC | 0.90 | 6,287 | +0.0 | 03/31/2026 |
| JPMorgan Chase & Co | 0.75 | 5,209 | +0.0 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.31 | 2,184 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.26 | 1,840 | +6.5 | 03/31/2026 |
| Westside Investment Management, Inc. | 0.22 | 1,525 | -4.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 0.90 | 6,287 | +0.0 | 07/31/2026 |
| Fidelity Extended Market Index | 0.48 | 3,315 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Duhay Francis | Director | 2,351 | 21,159 $ | Sep 11, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Duhay Francis | Director | Sell | 11 | 11.21 | 123 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.